Submucosal Injections Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2031

According to the latest research by FMI, submucosal injections market is set to witness a 7.3% growth during the year 2021-2031. The global demand for submucosal injections is expected to grow at a moderate pace during the forecast period. The submucosal injections are required principally during the endoscopic mucosal resection techniques.

They are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus. The most common submucosal agents are dextrose water, hydroxypropyl methylcellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.

What is Driving Demand for Submucosal Injections?

Submucosal injections are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus.

The use of these injections thus accounts for the minimization of adverse effects and untangles polypectomy. The rise in the application of submucosal injections is attributed to the increasing cases of several cancer types and their use in surgeries for the helpful removal of cancer cells before their growth. The factor of this technique being less invasive allows greater adoption of submucosal injections.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13375

Which Factors are Likely to Augment Growth of Submucosal Injection Adoption?

The augmentative factors which are expected to propel the development of submucosal injections are the increasing demand for endoscopic procedures, especially in the developed economies. Additionally, the rise in the number of patients with the intention of seeking treatment for early stage stomach cancer or premature cancer has also assisted with the increased growth and demand for submucosal injections.

Also, the introduction of new submucosal lifting agents such as, the development of Eleview by Cosmo Pharmaceuticals N.V., which is a ready-to-use and safe submucosal lifting agent, has led to advanced research and adoption of submucosal injections.

US and Canada Submucosal Injections Outlook

The submucosal injections value is likely to experience a lucrative growth in the region of North America. The countries US and Canada amount to the largest share in the submucosal injections application. According to the US National Cancer Institute, cancer incidence rate is 442.4 per 100,0000 men and women per year.

The increasing cases of several cancer types which include gastro, esophageal and colorectal cancers in these countries has accounted for the increase in demand of submucosal injections. Additionally, the demand is also gaining traction because of advanced healthcare infrastructure as well as favorable reimbursement policies in North America.

Europe Demand Outlook for Submucosal injections

The Europe submucosal injections sales is set to gain significant traction due to the increasing healthcare expenditure. The incidence rate of primarily esophageal cancer in the U.K. and Netherlands is highly standardized. The advancement of technology in terms of treatment of early stomach cancer, intestinal cancer and esophageal cancer is set to advance the European submucosal injections growth.

Who are the Key Manufacturers and Suppliers of Submucosal injections?

The key manufacturers of the submucosal injections are

  • Bio Space Inc.
  • GI Supply Cosmo Pharmaceuticals N.V.
  • FUJIFILM Medical Systems
  • Medtronic Plc.
  • Zeon Medical
  • Boston Scientific
  • Aries Pharmaceuticals
  • Sumitomo Bakelite Co.
  • ERBE Elektromedizin GmbH
  • Ovesco Endoscopy AG

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13375

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Posted on

Leave a Reply

Your email address will not be published.